ADVERTISEMENT
News
Diabetes Tablets Recalled
01/21/2021
The recall affects 100-count metformin hydrochloride extended-release tablets, 750 mg (NDC 29033-056-01), from lot MET200501 (Exp. 7/22). The tablets were distributed throughout the United States.
Nostrum Laboratories voluntarily initiated the recall January 4, 2021. On January 14, 2021, the FDA designated the recall Class II, signaling use of the product could cause temporary or medically reversible adverse health consequences. A remote possibility of serious harm also exists.
Metformin is a prescription medication used to help control blood sugar levels in people with type 2 diabetes.
—Jolynn Tumolo